Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Rossi

Showing results (121-130 of 339) with videos related to

Pageof 34
Sort By:
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance DatabaseRosanna Ruggiero, Annamaria Mascolo, Angela Spezzaferri, et al.
European Journal of Pharmacology|August 24, 2004
M40403 prevents myocardial injury induced by acute hyperglycaemia in perfused rat heartClara Di Filippo, Salvatore Cuzzocrea, Raffaele Marfella, et al.
International Journal of Molecular Medicine|November 8, 2005
Carotid arteriotomy induces different temporal gene expression profiles in normotensive and hypertensive rat strainsAmalia Forte, Umberto Galderisi, Marisa De Feo, et al.
Expert Opinion on Drug Safety|November 24, 2016
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania RegionLiberata Sportiello, Concetta Rafaniello, Maria Giuseppa Sullo, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma<sup>®</sup>) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting SystemRosanna Ruggiero, Nunzia Balzano, Maria Maddalena Nicoletti, et al.
Frontiers in Pharmacology|September 1, 2023
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLLAnnamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, et al.
Frontiers in Immunology|October 20, 2022
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax studyAnnamaria Mascolo, Gabriella di Mauro, Federica Fraenza, et al.
Mediators of Inflammation|October 19, 2006
Plasma levels of t-PA and PAI-1 correlate with the formation of experimental post-surgical peritoneal adhesionsClara Di Filippo, Alessandro Falsetto, Vito De Pascale, et al.
Pharmacological Research|July 12, 2017
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reportingAnnamaria Mascolo, Cristina Scavone, Maurizio Sessa, et al.
British Journal of Pharmacology|November 22, 2005
Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid arteryBarbara Rinaldi, Paolo Romagnoli, Stefano Bacci, et al.
Pageof 34

Showing results (121-130 of 339) with videos related to

Sort By:
Pageof 34
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance DatabaseRosanna Ruggiero, Annamaria Mascolo, Angela Spezzaferri, et al.
European Journal of Pharmacology|August 24, 2004
M40403 prevents myocardial injury induced by acute hyperglycaemia in perfused rat heartClara Di Filippo, Salvatore Cuzzocrea, Raffaele Marfella, et al.
International Journal of Molecular Medicine|November 8, 2005
Carotid arteriotomy induces different temporal gene expression profiles in normotensive and hypertensive rat strainsAmalia Forte, Umberto Galderisi, Marisa De Feo, et al.
Expert Opinion on Drug Safety|November 24, 2016
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania RegionLiberata Sportiello, Concetta Rafaniello, Maria Giuseppa Sullo, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma<sup>®</sup>) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting SystemRosanna Ruggiero, Nunzia Balzano, Maria Maddalena Nicoletti, et al.
Frontiers in Pharmacology|September 1, 2023
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLLAnnamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, et al.
Frontiers in Immunology|October 20, 2022
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax studyAnnamaria Mascolo, Gabriella di Mauro, Federica Fraenza, et al.
Mediators of Inflammation|October 19, 2006
Plasma levels of t-PA and PAI-1 correlate with the formation of experimental post-surgical peritoneal adhesionsClara Di Filippo, Alessandro Falsetto, Vito De Pascale, et al.
Pharmacological Research|July 12, 2017
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reportingAnnamaria Mascolo, Cristina Scavone, Maurizio Sessa, et al.
British Journal of Pharmacology|November 22, 2005
Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid arteryBarbara Rinaldi, Paolo Romagnoli, Stefano Bacci, et al.
Pageof 34